nominally significantp = .008
Differences in drop seizure reduction between placebo and CBD emerged during the titration period and became nominally significant by Day 6 ( p = .008) for pooled CBD treatment groups.
Differences in drop seizure reduction between placebo and CBD emerged during the titration period and became nominally significant by Day 6 ( p = .008) for pooled CBD treatment groups.